Insulet
PODD
#985
Rank
NZ$35.11 B
Marketcap
$500.62
Share price
1.63%
Change (1 day)
60.65%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): NZ$0.54 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$1.98 Billion. In 2023 the company made an earning of NZ$0.43 Billion, an increase over its 2022 earnings that were of NZ$74.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.54 B24.65%
2023 NZ$0.43 B481.9%
2022 NZ$74.84 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$95.33 M18.51%
2019 NZ$80.44 M41.16%
2018 NZ$56.99 M-711.95%
2017 -NZ$9.32 Million-56.85%
2016 -NZ$21.59 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$63.68 Million31.04%
2013 -NZ$48.6 Million-21.96%
2012 -NZ$62.28 Million
2010 -NZ$59.4 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$93.5 Million209.75%
2006 -NZ$30.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$6.69 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.22 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.32 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.28 B 5,069.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.76 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.28 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$17.62 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA